SCHEMBL4300593

SCHEMBL4300593

COC(=O)c1cc(N(C)C)ccc1C(N)=S

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.41
GAA P10253 5/20 0.41
MAPT P10636 4/20 0.41
KDM4E B2RXH2 4/20 0.41
HSD17B10 Q99714 4/20 0.41
HPGD P15428 3/20 0.41
GLA P06280 2/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
ATM Q13315 1/20 0.41
TSHR P16473 3/20 0.41
ABL1 P00519 1/20 0.41
NQO2 P16083 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
KMT2A Q03164 2/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
PDK2 Q15119 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8762164 0.87 CA12 (0.47) ALDH1A1GAAMAPTKDM4EHSD17B10
SCHEMBL1129609 0.79 ALDH1A1 (0.58) ALDH1A1GAAMAPTKDM4EHSD17B10
SCHEMBL22749397 0.79 ALDH1A1 (0.62) ALDH1A1GAAMAPTKDM4EHSD17B10
SCHEMBL19874811 0.79 SLC16A3 (0.44) ALDH1A1GAAMAPTKDM4EHSD17B10
SCHEMBL30966775 0.78 KDM4E (0.47) ALDH1A1GAAMAPTKDM4EHSD17B10
SCHEMBL18015088 0.78 KDM4E (0.47) ALDH1A1GAAMAPTKDM4EHSD17B10
SCHEMBL17212684 0.78 LMNA (0.57) ALDH1A1GAAMAPTKDM4EHSD17B10
Hydrochloric Acid SCHEMBL296819 0.78 ALDH1A1 (0.57) ALDH1A1GAAMAPTKDM4EHSD17B10
SCHEMBL21775704 0.77 CA12 (0.62) ALDH1A1GAAKDM4EHSD17B10HPGD
SCHEMBL3165135 0.77 CA12 (0.62) ALDH1A1GAAMAPTKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof WYETH (US) 2009-10-29 US disclosed
US-20090270447-A1 2-Aryl-and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof WYETH (US) 2009-10-29 US disclosed
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof WYETH (US) 2009-10-29 US disclosed
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof WYETH (US) 2009-10-29 US disclosed
US-20090270447-A1 2-Aryl-and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof WYETH (US) 2009-10-29 US disclosed
WO-2009120826-A1 2-ARYL- AND 2-HETEROARYLTHIAZOLYL COMPOUNDS, METHODS FOR THEIR PREPARATION AND USE THEREOF WYETH (US) 2009-10-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof SEC63, SEC62, SEC22B ALDH1A1 2705/4885GAA 1534/4885MAPT 2418/4885
US-20090270447-A1 2-Aryl-and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof CYP2U1, SEC22B, SEC63 ALDH1A1 1461/4885GAA 1533/4885MAPT 2878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.